299 related articles for article (PubMed ID: 24447695)
1. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; Alvarez-Sánchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martínez-Castrillo JC; Mendoza-Rodríguez A; Moore HP; Rodríguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
Eur J Neurol; 2014 Mar; 21(3):519-24. PubMed ID: 24447695
[TBL] [Abstract][Full Text] [Related]
2. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease.
Rodriguez-Blazquez C; Rojo-Abuin JM; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Oct; 19(10):889-93. PubMed ID: 23791519
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
[TBL] [Abstract][Full Text] [Related]
4. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.
Ueno T; Kon T; Haga R; Nishijima H; Arai A; Tomiyama M
Neurol Sci; 2020 Oct; 41(10):2867-2873. PubMed ID: 32328832
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.
Skorvanek M; Martinez-Martin P; Kovacs N; Zezula I; Rodriguez-Violante M; Corvol JC; Taba P; Seppi K; Levin O; Schrag A; Aviles-Olmos I; Alvarez-Sanchez M; Arakaki T; Aschermann Z; Benchetrit E; Benoit C; Bergareche-Yarza A; Cervantes-Arriaga A; Chade A; Cormier F; Datieva V; Gallagher DA; Garretto N; Gdovinova Z; Gershanik O; Grofik M; Han V; Kadastik-Eerme L; Kurtis MM; Mangone G; Martinez-Castrillo JC; Mendoza-Rodriguez A; Minar M; Moore HP; Muldmaa M; Mueller C; Pinter B; Poewe W; Rallmann K; Reiter E; Rodriguez-Blazquez C; Singer C; Valkovic P; Goetz CG; Stebbins GT
Parkinsonism Relat Disord; 2018 Jul; 52():83-89. PubMed ID: 29625875
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.
Kadastik-Eerme L; Rosenthal M; Paju T; Muldmaa M; Taba P
Health Qual Life Outcomes; 2015 Jun; 13():83. PubMed ID: 26088201
[TBL] [Abstract][Full Text] [Related]
7. The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP).
He L; Lee EY; Sterling NW; Kong L; Lewis MM; Du G; Eslinger PJ; Huang X
J Parkinsons Dis; 2016 May; 6(3):523-32. PubMed ID: 27258700
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.
Martínez-Martín P; Rodríguez-Blázquez C; Mario Alvarez ; Arakaki T; Arillo VC; Chaná P; Fernández W; Garretto N; Martínez-Castrillo JC; Rodríguez-Violante M; Serrano-Dueñas M; Ballesteros D; Rojo-Abuin JM; Chaudhuri KR; Merello M
Parkinsonism Relat Disord; 2015 Jan; 21(1):50-4. PubMed ID: 25466406
[TBL] [Abstract][Full Text] [Related]
9. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
[TBL] [Abstract][Full Text] [Related]
10. The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.
Schrag A; Selai C; Jahanshahi M; Quinn NP
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):67-73. PubMed ID: 10864606
[TBL] [Abstract][Full Text] [Related]
11. Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease.
Dams J; Klotsche J; Bornschein B; Reese JP; Balzer-Geldsetzer M; Winter Y; Schrag A; Siderowf A; Oertel WH; Deuschl G; Siebert U; Dodel R
Health Qual Life Outcomes; 2013 Mar; 11():35. PubMed ID: 23497005
[TBL] [Abstract][Full Text] [Related]
12. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.
Martinez-Martin P; Chaudhuri KR; Rojo-Abuin JM; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
Eur J Neurol; 2015 Jan; 22(1):37-43. PubMed ID: 23607783
[TBL] [Abstract][Full Text] [Related]
13. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Goetz CG; Tilley BC; Shaftman SR; Stebbins GT; Fahn S; Martinez-Martin P; Poewe W; Sampaio C; Stern MB; Dodel R; Dubois B; Holloway R; Jankovic J; Kulisevsky J; Lang AE; Lees A; Leurgans S; LeWitt PA; Nyenhuis D; Olanow CW; Rascol O; Schrag A; Teresi JA; van Hilten JJ; LaPelle N;
Mov Disord; 2008 Nov; 23(15):2129-70. PubMed ID: 19025984
[TBL] [Abstract][Full Text] [Related]
14. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
Santos-García D; de la Fuente-Fernández R
J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in a German cohort of Parkinson's patients assessed with three different measures.
Balzer-Geldsetzer M; Klotsche J; ; Dodel R; Riedel O
J Neurol; 2018 Nov; 265(11):2713-2722. PubMed ID: 30209651
[TBL] [Abstract][Full Text] [Related]
16. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
[TBL] [Abstract][Full Text] [Related]
17. Handicap as a Measure of Perceived-Health Status in Parkinson's Disease.
Silva DP; Coelho M; Soares T; Vale TC; Correia Guedes L; Maciel ROH; Antunes AP; Camargos ST; Valadas A; Godinho C; Maia DP; Pita Lobo P; Maia RD; Teodoro T; Rieder CR; Velon AG; Tumas V; Barbosa ER; Teive HAG; Ferraz HB; Rosas MJ; Calado A; Lampreia T; Simões R; Vila-Chã N; Costa MM; Rodrigues AM; Caniça V; Cardoso F; Ferreira JJ;
Mov Disord Clin Pract; 2023 Aug; 10(8):1172-1180. PubMed ID: 37635780
[TBL] [Abstract][Full Text] [Related]
18. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study.
Juhász A; Aschermann Z; Ács P; Janszky J; Kovács M; Makkos A; Harmat M; Tényi D; Karádi K; Komoly S; Takáts A; Tóth A; Nagy H; Klivényi P; Dibó G; Dézsi L; Zádori D; Annus Á; Vécsei L; Varannai L; Kovács N
Parkinsonism Relat Disord; 2017 Apr; 37():79-86. PubMed ID: 28185758
[TBL] [Abstract][Full Text] [Related]
19. Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease.
Li H; Zhang M; Chen L; Zhang J; Pei Z; Hu A; Wang Q
Mov Disord; 2010 Dec; 25(16):2740-6. PubMed ID: 20945434
[TBL] [Abstract][Full Text] [Related]
20. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
Martinez-Martin P; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
J Neurol; 2013 Jan; 260(1):228-36. PubMed ID: 22865238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
